Get started
Markets India Stocks Health Technology Pharmaceuticals: Major

TORRENT PHARMACEUTICALS LTD TORNTPHARM

TORNTPHARMBSE
TORNTPHARM
TORRENT PHARMACEUTICALS LTDBSE
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals Forecast

TORNTPHARM chart

Ideas

Double BOTTOM - SIMPLE AND POWERFUL
TORNTPHARM
, 1DLong
TORNTPHARM: Double BOTTOM - SIMPLE AND POWERFUL

Dear friends, I explained everything in chart. Happy investing. Regards, Indian Ox

Tornt Pharma 2960 b 5th Aug
TORNTPHARM
, 1DLong
TORNTPHARM: Tornt Pharma 2960 b 5th Aug
Updated 

Tornt Pharma 2960 b 5th Aug

Torrent Pharma: On the verge of fresh uptrend?
TORNTPHARM
, 60Long
TORNTPHARM: Torrent Pharma: On the verge of fresh uptrend?

Torrent Pharma seems to have completed wave (iv) correction and now might be heading towards wave (v) which is expected to terminate anywhere between 2730 to 2800. Follow up price action from here would be interesting. Minor hurdle is around 2580 which if crossed we may see a strong impulsive move on the upside.

Intraday Setup Torrent Pharma !!
TORNTPHARM
, 15Short
TORNTPHARM: Intraday Setup Torrent Pharma !!

Follow Chart Instruction. Take Entry at given level if comes. Risk Reward 7-10 times.

Long TORNTPHARMA
TORNTPHARM
, 1DLong
TORNTPHARM: Long TORNTPHARMA
Updated 

Long TORNTPHARM

short the stock
TORNTPHARM
, DShort
TORNTPHARM: short the stock

as we can see that there was a bearish engulfing pattern few days ago and and today bearish kicker signal there and price below 8ema and bearish divergence add to it.

buy call
TORNTPHARM
, DLong
TORNTPHARM: buy call

as we can see the bullish divergence there and bullish kicker signal and the market coming from a oversold area i prefer to go long

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins}
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.

News flow

More news